Eddit

Aus coViki
(Unterschied zwischen Versionen)
Wechseln zu: Navigation, Suche
 
(73 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt)
Zeile 1: Zeile 1:
 
__NOTOC__
 
__NOTOC__
 
*'''[[Further reading]]'''
 
*'''[[Further reading]]'''
 +
  
 
*'''[[Unproven ideas]]'''
 
*'''[[Unproven ideas]]'''
 +
 
*'''[[Reviews on covid19 disease]]'''
 
*'''[[Reviews on covid19 disease]]'''
{{tp|p=32202343|t=ä. Systematic review of COVID?19 in children shows milder cases and a better prognosis than adults |pdf=|usr=}}
 
 
*'''[[Clinical guidelines and advice]]'''
 
*'''[[Clinical guidelines and advice]]'''
 +
  
  
Zeile 11: Zeile 13:
  
 
*'''[[Diagnosis (Laboratory)]]'''
 
*'''[[Diagnosis (Laboratory)]]'''
 +
  
 
*'''[[Diagnosis (Lung CT, Sonography)]]'''
 
*'''[[Diagnosis (Lung CT, Sonography)]]'''
 +
 
*'''[[Diagnosis (other modalities)]]'''
 
*'''[[Diagnosis (other modalities)]]'''
  
----
+
 
  
  
Zeile 23: Zeile 27:
 
*'''[[Target binding and uptake]]'''
 
*'''[[Target binding and uptake]]'''
 
*'''[[Cytopathic effects]]'''
 
*'''[[Cytopathic effects]]'''
 
 
*'''[[Secretion and shedding]]'''
 
*'''[[Secretion and shedding]]'''
  
Zeile 31: Zeile 34:
  
 
*'''[[Immunology]]'''
 
*'''[[Immunology]]'''
 
  
 
*'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]'''
 
*'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]'''
  
----
+
 
 +
 
 
*'''[[Pathobiology]]'''
 
*'''[[Pathobiology]]'''
{{tp|p=32379417|t=ä. Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age |pdf=|usr=}}
+
 
  
 
*'''[[Disease Models]]'''
 
*'''[[Disease Models]]'''
 +
  
 
*'''[[Similar diseases and pathomechanisms]]'''
 
*'''[[Similar diseases and pathomechanisms]]'''
  
 
----
 
  
  
Zeile 51: Zeile 53:
  
 
*'''[[Systemic disease, any manifestations]]'''
 
*'''[[Systemic disease, any manifestations]]'''
 +
 
*'''[[Co-Infection]]'''
 
*'''[[Co-Infection]]'''
  
*'''[[ARDS]]'''
 
  
 
*'''[[Pulmonary embolism, coagulation]]'''
 
*'''[[Pulmonary embolism, coagulation]]'''
  
  
*'''[[Hematology]]'''
 
  
 +
 +
 +
*'''[[Hematology]]'''
  
  
  
 
*'''[[Heart]]'''
 
*'''[[Heart]]'''
 +
  
  
 
*'''[[Neurology, ophthalmology, orl]]'''
 
*'''[[Neurology, ophthalmology, orl]]'''
{{tp|p=32285431|t=2020. Novel Coronavirus Disease (COVID-19) and Central Nervous System Complications: What Neurologist Need to Know |pdf=|usr=}}
+
 
 +
 
  
 
*'''[[Dermatology]]'''
 
*'''[[Dermatology]]'''
 +
  
  
 
*'''[[Gastroenterology, hepatology]]'''
 
*'''[[Gastroenterology, hepatology]]'''
 +
 
*'''[[Kidney, urology]]'''
 
*'''[[Kidney, urology]]'''
  
 +
*'''[[The morbid survivor]]'''
  
 
*'''[[Risk and special populations]]'''
 
*'''[[Risk and special populations]]'''
  
*'''[[The morbid survivor]]'''
+
 
{{tp|p=32364491|t=ä. Are COVID-19 survivors at increased risk for suicide?|pdf=|usr=}}
+
  
 
*'''[[Case reports]]'''
 
*'''[[Case reports]]'''
 +
 +
 +
 +
 +
 +
  
 
*'''[[Case series]]'''
 
*'''[[Case series]]'''
 +
 +
 
*'''[[Registries]]'''
 
*'''[[Registries]]'''
----
 
  
  
Zeile 91: Zeile 106:
  
 
*'''[[Candidate Compounds Covid19]]'''
 
*'''[[Candidate Compounds Covid19]]'''
----
 
  
  
 
*'''[[Other routes of infection]]'''
 
*'''[[Other routes of infection]]'''
{{tp|p=32189463|t=ä. The possibility of COVID?19 transmission from eye to nose |pdf=|usr=}}
 
{{tp|p=32189460|t=ä. There may be virus in conjunctival secretion of patients with COVID?19 |pdf=|usr=}}
 
 
  
  
 
*'''[[Biophysics of aerosols]]'''
 
*'''[[Biophysics of aerosols]]'''
  
*'''[[Passive protective equipment]]'''
 
  
*'''[[Running your hospital]]'''
 
{{tp|p=32377950|t=ä. Are we forgetting non-COVID-19-related diseases during lockdown?|pdf=|usr=}}
 
  
  
 +
*'''[[Passive protective equipment]]'''
  
*'''[[Mental aspects of health professionals]]'''
 
  
  
 +
*'''[[Running your hospital]]'''
  
  
 +
*'''[[Mental aspects of health professionals]]'''
 +
 +
*'''[[Socio-psychiatric aspects of the status hygienicus]]'''
  
  
  
*'''[[Socio-psychiatric aspects of the status hygienicus]]'''
 
  
 
*'''[[Avoiding clinical medicine in other diseases]]'''
 
*'''[[Avoiding clinical medicine in other diseases]]'''
 +
  
  
Zeile 126: Zeile 138:
  
 
*'''[[Economic aspects of the status hygienicus]]'''
 
*'''[[Economic aspects of the status hygienicus]]'''
 +
 +
 
*'''[[Educational aspects of the status hygienicus]]'''
 
*'''[[Educational aspects of the status hygienicus]]'''
 
----
 
----
Zeile 133: Zeile 147:
  
 
*'''[[Origin of Covid19]]'''
 
*'''[[Origin of Covid19]]'''
 
  
 
*'''[[Epidemiology]]'''
 
*'''[[Epidemiology]]'''
  
  
*'''[[Remission, recurrence and persistence]]'''
 
  
*'''[[Failure of executive measures]]'''
 
  
  
 +
*'''[[Remission, recurrence and persistence]]'''
  
 +
 +
 +
*'''[[Failure of executive measures]]'''
 
----
 
----
 
*'''[[Failure of politics and public health guidance]]'''
 
*'''[[Failure of politics and public health guidance]]'''
 +
  
 
*'''[[Political abuse of Covid19]]'''
 
*'''[[Political abuse of Covid19]]'''
 +
  
  
Zeile 153: Zeile 170:
  
 
*'''[[Lost civilization]]'''
 
*'''[[Lost civilization]]'''
 +
 
----
 
----
  
  
 
*'''[[History of covid19 exploration]]'''
 
*'''[[History of covid19 exploration]]'''
 +
*'''[[misc.]]'''
  
*'''[[misc.]]'''}}
 
  
 
*'''[[Research tools]]'''
 
*'''[[Research tools]]'''
  
 +
 +
 +
 +
{{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}}
 +
{{tp|p=25040500|t=2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system |pdf=|usr=}}
  
  
 
*'''[[PrePrint scene]]'''
 
*'''[[PrePrint scene]]'''
 +
 +
 
*'''[[from the ads]]'''
 
*'''[[from the ads]]'''
 +
 
*'''[[Current state of coviki.org]]'''
 
*'''[[Current state of coviki.org]]'''
 +
*'''[[on-topic personal thoughts]]'''

Aktuelle Version vom 7. Juni 2020, 22:19 Uhr



















































27490990 2017. AVCpred: an integrated web server for prediction and design of antiviral compounds
25040500 2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system



Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge
Blogverzeichnis - Blog Verzeichnis bloggerei.deBlogverzeichnis